Brief: Pulse Biosciences Announces Strategic Alignment To Accelerate Cardiac Catheter Program Following Exceptional Long-Term Afib Clinical Data
17/03/2026 11:53
March 17 (Reuters) - Pulse Biosciences Inc PLSE.O: PULSE BIOSCIENCES ANNOUNCES STRATEGIC ALIGNMENT TO ACCELERATE CARDIAC CATHETER PROGRAM FOLLOWING EXCEPTIONAL LONG-TERM AFIB CLINICAL DATA Source text: ID:nBw7n96HQa Further company coverage: PLSE.O ((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Pulse Biosciences
See all newsBrief: Pulse Biosciences, Inc. Announces Planned Redemption Of Warrants
Chairmen Total Approximately $13.3 Million
Pulse Biosciences records Q1 revenue, but loss widens on higher clinical investment
Brief: Pulse Biosciences Q1 Net Income USD -18.581 Million
Brief: Pulse Biosciences Announces Positive Clinical Data From Npulse Cardiac Catheter System